Changing the Status Quo of Traditional Drug Development
Our technology allows deeper insight into the effects and potential treatments of metabolic diseases to mitigate impact on human health and streamline the translation from R&D to clinical trials.
our vision
We envision a world where enriched preclinical insights create future therapies that are accessible, equitable, and effective for patients worldwide regardless of demographic and socioeconomic backgrounds.
our technology
We offer human-derived hydrogels, stem cells, and functional Fat-on-a-chip models for pre-clinical drug development.
Our Partners
Our strategic partnerships with distinguished industry leaders not only enhance our company's capabilities but also foster innovation, synergy, and collective success through collaborative efforts.
Our investors
The unwavering support of our investors not only ensures stability but also propels our company towards greater innovation, enabling us to bring our vision closer to reality with every milestone achieved.